Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NATCO gets tentative US FDA approval for Ibrutinib tablets

expresspharmaApril 12, 2021

Tag: NATCO , Alvogen , Ibrutinib tablets , Imbruvica

PharmaSources Customer Service